Charles Large, Autifony CEO, talks at the 8th Sachs Neuroscience Innovation Forum in San Francisco

29 January 2025

Charles Large, Autifony’s CEO, talks at the 8th Sachs Neuroscience Innovation Forum in San Francisco (January 2025). Dr Large talks about Autifony’s clinical-stage, Kv3 ion channel programme and how advances in the use of biomarkers to understand the pathology of neuropsychiatric and neurological disorders is opening up opportunities for targeted, rational treatments.